Regenerative Medicine Venturing at the University-Industry Boundary: Implications for Institutions, Entrepreneurs, and Industry
- 21 September 2018
- book chapter
- Published by Springer Nature
- Vol. 1098, 213-236
Abstract
Regenerative medicine research at university laboratories has outpaced commercial activity. Legal, regulatory, funding, technological, and operational uncertainty have slowed market entry of regenerative medicine treatments. As a result, commercial development has often been led by entrepreneurial ventures rather than large biopharma firms. Translating regenerative medicine across the university-industry boundary links academic scientists, technology transfer organizations, funders, and entrepreneurs. Conflicting motivations among the participants may significantly hinder these efforts. Unproven downstream business models for regenerative medicine delivery further complicate the entrepreneurial process. This chapter explores the challenges associated with entrepreneurial activity commercializing regenerative medicine science developed at research institutions.Keywords
This publication has 47 references indexed in Scilit:
- The Effects of Culture and Structure on Strategic Flexibility during Business Model InnovationJournal of Management Studies, 2011
- Clinical trials for stem cell therapiesBMC Medicine, 2011
- The Business Model in Practice and its Implications for Entrepreneurship ResearchEntrepreneurship Theory and Practice, 2011
- Stay in the Game: Gender, Family Formation and Alternative Trajectories in the Academic Life CourseSocial Forces, 2009
- Entry into Insular Domains: A Longitudinal Study of Knowledge Structuration and Innovation in Biotechnology FirmsJournal of Management Studies, 2008
- Top Management Teams, Business Models, and Performance of Biotechnology Ventures: An Upper Echelon Perspective*British Journal of Management, 2008
- The global stem cell patent landscape: implications for efficient technology transfer and commercial developmentNature Biotechnology, 2007
- If star scientists do not patent: The effect of productivity, basicness and impact on the decision to patent in the academic worldResearch Policy, 2007
- Business models in Italian biotechnology industry: a quantitative analysisTechnovation, 2005
- Interorganizational Collaboration and the Locus of Innovation: Networks of Learning in BiotechnologyAdministrative Science Quarterly, 1996